GHRP-2: The Powerful GH Secretagogue

Category: Protocols Type: Protocol Read Time: 16 minutes Author: Peptides.NYC Editorial Last Updated: 2026-05-19 URL: https://peptides.nyc/learn/ghrp-2-protocol

Educational content only. Not medical advice. Consult a licensed healthcare provider before starting any protocol.

Overview

GHRP-2 (Growth Hormone Releasing Peptide-2), also known as KP-102 or pralmorelin, is a synthetic hexapeptide and a potent ghrelin receptor agonist. Developed in the 1980s by Cyril Bowers and colleagues as part of the original GHRP family, it remains one of the strongest growth hormone secretagogues per microgram available to researchers.

Compared to its older sibling GHRP-6, GHRP-2 produces a stronger pulse of growth hormone (GH) with significantly less appetite stimulation, making it the preferred choice for users who want GH benefits without ghrelin-driven hunger.

Key Properties

• Sequence: D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2 (six amino acids)
• Class: Growth hormone secretagogue (GHS); ghrelin/GHSR-1a agonist
• Half-life: Approximately 15–30 minutes
• Route: Subcutaneous injection (most common); intranasal forms exist
• Status: Not FDA-approved in the U.S.; banned by WADA in all sports
• Use case: Pulsatile GH amplification, recovery, sleep depth, body composition support

Mechanism of Action

GHRP-2 mimics ghrelin, the body's natural "hunger hormone," but its primary clinical relevance is its action at the growth hormone secretagogue receptor (GHSR-1a) on the pituitary and hypothalamus.

Pathways

1. Direct pituitary stimulation — Binds GHSR-1a on somatotrophs, triggering immediate GH release
2. Somatostatin suppression — Reduces the brain's natural "brake" on GH output
3. GHRH synergy — Combined with a GHRH analog (CJC-1295, Sermorelin), the GH pulse is far greater than either peptide alone — a true 1+1=3 effect
4. Endogenous pulsatility — Unlike rHGH, the resulting pulse stays under negative feedback control, preserving natural GH rhythm

Dosing Protocols

GHRP-2 follows the same "saturation dose" principle as other GHRPs. Beyond roughly 100 mcg per dose, additional peptide produces diminishing returns and increases side effects (cortisol, prolactin) without proportionally more GH.

Standard Dosing Table

Timing Windows

• Pre-bed (most important): 100–200 mcg ~30 minutes before sleep to amplify the natural overnight GH pulse
• AM fasted: 100–200 mcg upon waking, 15–30 minutes before food
• Post-workout: 100–200 mcg within 30 minutes after training

Food Timing Rule

Eat no carbohydrates or fats within 2 hours before or 30 minutes after an injection. Elevated insulin and free fatty acids blunt the GH pulse significantly.

Weight-Based Reference

• ~1 mcg/kg per dose is the practical saturation point
• 75kg user → ~75–100 mcg per pulse is biologically maximal

GHRP-2 vs GHRP-6 vs Ipamorelin vs Hexarelin

The four major GHRPs differ meaningfully in potency, side effect profile, and use case.

Quick Decision Guide

• Want maximum GH per microgram, OK with mild cortisol/appetite? → GHRP-2
• Need appetite stimulation (cachexia, hardgainer)? → GHRP-6
• Want clean GH with no cortisol/prolactin/hunger? → Ipamorelin
• Short, aggressive cycles for recomp? → Hexarelin (but rapid desensitization)

Expected Outcomes

Realistic timelines based on user reports and small clinical studies. Individual response varies significantly.

Week 1–2: Sleep & Recovery Onset

• Deeper, more restorative sleep (most consistent benefit)
• Vivid dreams reported by many users
• Reduced muscle soreness post-training
• Mild flushing or warmth at injection time

Week 2–4: Recovery & Subjective Energy

• Faster between-session recovery
• Improved skin quality, hair, and nails
• Modest increase in fasting energy
• Some mild water retention may appear

Week 4–12: IGF-1 Climb and Composition Shifts

• Serum IGF-1 typically rises 20–40% from baseline
• Improved subjective well-being and joint comfort
• Modest fat loss, particularly visceral
• Small lean mass gains with training and adequate protein
• Effects are subtle compared to exogenous rHGH — manage expectations

Side Effects & Safety

GHRP-2 is generally well-tolerated at saturation doses but is not as "clean" as Ipamorelin.

Common (mild, usually transient)

• Facial flushing or warmth (5–15 minutes post-injection)
• Mild head rush or tingling
• Mild appetite increase (much less than GHRP-6)
• Injection site reactions
• Water retention, especially first 2 weeks

Less Common

• Transient cortisol elevation (vs. Ipamorelin's neutral profile)
• Transient prolactin elevation
• Mild numbness in extremities (CTS-like)
• Headache
• Reduced insulin sensitivity over long cycles

The Cortisol/Prolactin Question

GHRP-2 produces a measurable but typically modest rise in cortisol and prolactin compared to Ipamorelin. For most users this is clinically insignificant. Those with existing prolactin issues, mood disorders, or stress-axis dysfunction may prefer Ipamorelin.

Contraindications

• Active or history of cancer (GH/IGF-1 raises theoretical concern)
• Pregnancy and breastfeeding
• Active diabetic retinopathy
• Severe insulin resistance (use caution; monitor glucose)
• Anyone using exogenous rHGH (redundant and risky stacking)

Stacking

GHRP-2 + CJC-1295 (No DAC) — The Classic

The gold-standard GHRP/GHRH pair. The two peptides hit complementary mechanisms and produce a sharp, physiological GH pulse.

• CJC-1295 No DAC: 100 mcg per dose
• GHRP-2: 100–200 mcg per dose
• Frequency: 2–3x daily (pre-bed mandatory)
• Notes: Inject simultaneously in the same syringe

GHRP-2 + Sermorelin

A gentler GHRH option for users who want a smoother profile or are early in their GH peptide journey.

• Sermorelin: 100–300 mcg pre-bed
• GHRP-2: 100–200 mcg pre-bed

GHRP-2 + BPC-157 (Recovery Stack)

For injury recovery alongside GH support.

• GHRP-2: 200 mcg, 2–3x daily
• BPC-157: 250–500 mcg daily

What to Avoid

• Exogenous rHGH — already saturates feedback; GHRP-2 adds no benefit and increases side effects
• Multiple GHRPs together — they compete for the same receptor; pick one
• MK-677 simultaneously — both are GHSR agonists, leading to receptor desensitization

Cycling

GHRP-2 cycling is debated. Animal studies suggest some receptor desensitization with chronic use, while human data is less clear. Practical approach:

Standard Cycle

• On: 8–12 weeks
• Off: 4–8 weeks washout
• Rationale: Protect GHSR sensitivity, allow HPA axis to normalize, reassess bloodwork

Aggressive Cycle

• On: 12–16 weeks
• Off: 8 weeks
• Only after baseline cycles, with bloodwork checkpoints every 8 weeks

Continuous Use (Not Recommended)

Some users run GHRP-2 year-round. While endogenous pulsatility is preserved better than with rHGH, long-term safety data does not exist. Cycle for safety.

Bloodwork to Monitor

Baseline before starting, retest at 8–12 weeks on cycle, and again after washout.

Core Panel

• IGF-1 — Primary marker of GH activity; aim for upper-quartile age-adjusted range, not above
• Fasting glucose & HbA1c — GH lowers insulin sensitivity over time
• Fasting insulin — Track changes in metabolic response
• Prolactin — Especially if symptomatic (mood, libido, galactorrhea)
• Cortisol (AM) — Optional, useful if fatigue, weight gain, or sleep issues emerge
• Complete metabolic panel — Liver, kidney baseline

Optional / Symptom-Driven

• TSH and free T3/T4 (GH can affect thyroid conversion)
• Lipid panel (changes with body composition shifts)
• DHT and total testosterone (track endocrine stability)

Frequently Asked Questions

Q: GHRP-2 vs Ipamorelin — which should I choose? A: GHRP-2 is more potent per mcg and cheaper but raises cortisol and prolactin slightly. Ipamorelin is "clean" with negligible side effects but milder. New users seeking minimal risk often start with Ipamorelin; experienced users seeking maximum pulse choose GHRP-2.

Q: What does "saturation dose" mean? A: It is the dose above which additional peptide produces no extra GH release — only more side effects. For GHRP-2 this is approximately 100 mcg, or roughly 1 mcg/kg body weight. Going significantly higher wastes peptide and adds cortisol/prolactin without proportional benefit.

Q: Should I be worried about cortisol increases? A: For most users at saturation doses, the cortisol spike is transient and clinically irrelevant. If you have HPA-axis dysfunction, chronic stress, or sleep issues, Ipamorelin is the safer choice.

Q: Can I stack GHRP-2 with CJC-1295? A: Yes — this is the most common and effective stack. GHRH analogs (CJC-1295) and GHRPs (GHRP-2) work through different but synergistic mechanisms. Combined, they amplify the natural GH pulse far beyond either alone.

Q: Is GHRP-2 banned by WADA? A: Yes. All GH secretagogues — GHRP-2 included — are prohibited at all times under WADA's S2 category. If you compete in any tested sport, do not use GHRP-2.

Q: Will GHRP-2 make me hungry like GHRP-6? A: Much less so. GHRP-6 produces strong, rapid hunger via ghrelin signaling; GHRP-2 produces only mild appetite changes for most users. This is the main practical reason GHRP-2 is more popular than GHRP-6 in body composition contexts.

Q: How long until I see results? A: Sleep improvements often appear within 3–7 days. Recovery and skin/hair benefits emerge over 2–4 weeks. Body composition changes are subtle and require 8–12 weeks alongside training and nutrition.

Q: Can women use GHRP-2? A: Yes, dosing follows the same saturation principle. Many female users prefer Ipamorelin due to a cleaner prolactin profile, but GHRP-2 is widely used by women without issue at standard doses.

Quality & Reconstitution

What to Look For

• Third-party COA showing >98% purity (HPLC + mass spec)
• Lyophilized white powder appearance
• Reputable vendor with consistent batch testing
• Avoid pre-mixed solutions, missing COAs, suspiciously low prices

For a 5mg Vial

Standard: 2 mL BAC water → 2.5 mg/mL → 100 mcg = 4 units on an insulin syringe. Swirl gently, never shake, refrigerate after reconstitution, use within 3–4 weeks.

Regulatory & Legal Status

GHRP-2 is not approved by the FDA for any human use and is sold strictly as a research chemical. It is banned by WADA at all times in all sports. Possession laws vary by state; users are responsible for local regulations.

Related Content

• CJC-1295 Protocol Guide
• Ipamorelin Protocol Guide
• GH Peptide Stacking Guide
• MK-677 Protocol
• Bloodwork Checklist
• Reconstitution Cheat Sheet

Disclaimer: This content is for educational purposes only and is not medical advice. GHRP-2 is a research compound, is not FDA-approved for human use, and is banned by WADA. References to research by Bowers, Sigalos, and others reflect general scientific consensus on GH secretagogues. Consult a licensed healthcare provider before starting any peptide protocol.

Source: https://peptides.nyc/learn/ghrp-2-protocol